Composition for clearing spheroids, method for clearing spheroids using same, and kit comprising same
US-11365213-B2 · Jun 21, 2022 · US
US12399090B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12399090-B2 |
| Application number | US-202118010906-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 28, 2021 |
| Priority date | Jun 16, 2020 |
| Publication date | Aug 26, 2025 |
| Grant date | Aug 26, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A clearing pretreatment method of a biological sample having a size of at most 1 mm, that is, a spheroid or organoid, according to the present invention uses a phosphate-buffered saline (PBS) rather than a conventional sucrose solution as a pretreatment solution, thus solving the problem in which the spheroid or organoid floats above the surface of water due to the density difference such that the structure of the sample is damaged. Therefore, there is an effect in that the spheroid or organoid can be transparentized while maintaining the original shape thereof, thus making it possible to image deep parts.
Opening claim text (preview).
The invention claimed is: 1. A clearing method of a biological sample having a size of 1 mm or less, the method comprising: fixing a biological sample having a size of 1 mm or less; pretreating the fixed biological sample by contacting the fixed biological sample with a pretreatment solution consisting of phosphate-buffered saline (PBS) and incubating at 0° C. to 10° C.; and clearing the resulting pretreated biological sample by bringing the pretreated biological sample into contact with a clearing agent comprising a 3-[(3-cholamidopropyl)-dimethylammonio]-propane-sulfonate (CHAPS) compound of Formula 2 or a hydrate thereof in an amount of 2 to 55 w/v %, and urea in an amount of 10 to 70 w/v %, 2. The method of claim 1 , wherein the biological sample is a spheroid or an organoid. 3. The method of claim 2 , wherein the spheroid or organoid is formed from a cell derived from brain, blood vessels, liver, lungs, kidneys, pancreas, stomach, or intestines. 4. The method of claim 1 , wherein the biological sample has an average diameter in a range of 0.05 mm to 1 mm. 5. The method of claim 1 , wherein the biological sample is fixed by contacting the biological sample with at least one selected from the group consisting of paraformaldehyde, ethylene glycol diglycidyl ether, dipropylene glycol diglycidyl ether, 1,4-butanediol diglycidyl ether, glycerol polyglycidyl ether, glutaraldehyde, and polyacrylamide. 6. The method of claim 1 , further comprising contacting the pretreated biological sample, which has been removed or transferred from the PBS pretreatment solution, with agarose after the pretreating of the biological sample with PBS and before the clearing of the biological sample.
Fixative compositions · CPC title
Embedding or analogous mounting of samples · CPC title
Staining; Impregnating {; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis} · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.